A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC)
Condition(s):Renal Cell Carcinoma; Renal Cell Carcinoma MetastaticLast Updated:November 29, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Renal Cell Carcinoma; Renal Cell Carcinoma MetastaticLast Updated:November 29, 2022Recruiting
Condition(s):Renal Cancer; Renal Cell Carcinoma; Renal Cell Cancer MetastaticLast Updated:January 23, 2024Recruiting
Condition(s):Renal Cell CarcinomaLast Updated:December 29, 2023Recruiting
Condition(s):Renal Cell CarcinomaLast Updated:December 7, 2023Active, not recruiting
Condition(s):Metastatic Renal Cell CarcinomaLast Updated:February 21, 2024Recruiting
Condition(s):Kidney CancerLast Updated:December 17, 2020Unknown status
Condition(s):Renal Cell CarcinomaLast Updated:August 13, 2020Withdrawn
Condition(s):Carcinoma, Renal CellLast Updated:August 19, 2019Unknown status
Condition(s):Renal Cell Carcinoma (RCC)Last Updated:December 22, 2020Completed
Condition(s):Clear-cell Metastatic Renal Cell Carcinoma; Kidney NeoplasmsLast Updated:December 7, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.